Photo of Raymond J. Kelleher, MD, PhD

Raymond J. Kelleher, MD, PhD


Accepting New Patients




Clinical Interests
  • Alzheimer's disease
  • Dementia
  • Memory disorders
Medical Education
  • MD, PhD, Stanford University School of Medicine
  • Residency, Massachusetts General Hospital
  • Fellowship, Massachusetts General Hospital
  • Boston: Massachusetts General Hospital
Patient Gateway
Yes, learn more
Insurances Accepted
  • Aetna Health Inc.
  • Beech Street
  • Blue Cross Blue Shield - Blue Care 65
  • Blue Cross Blue Shield - Indemnity
  • Blue Cross Blue Shield - Managed Care
  • Blue Cross Blue Shield - Partners Plus
  • Centene/Celticare
  • Cigna (PAL #'s)
  • Fallon Community HealthCare
  • Great-West Healthcare (formally One Health Plan)
  • Harvard Pilgrim Health Plan - PBO
  • Health Care Value Management (HCVM)
  • Humana/Choice Care PPO
  • Medicaid
  • Medicare
  • Medicare - ACD
  • Neighborhood Health Plan - ACD
  • Neighborhood Health Plan - PBO
  • OSW - Maine
  • OSW - New Hampshire
  • OSW - Rhode Island
  • Private Health Care Systems (PHCS)
  • Senior Whole Health
  • TriCare
  • Tufts Health Plan
  • Unicare
  • United Healthcare (non-HMO) - ACD
  • United Healthcare (non-HMO) - PBO
Patient Age Group

Edit Profile

Research & Publications

Research Summary

The Kelleher laboratory studies the molecular and cellular mechanisms underlying cognition and cognitive disorders. Our prior work established an essential role for translational regulation in long-lasting forms of synaptic plasticity and memory, and further defined an essential MAPK-dependent pathway coupling synaptic activation to the dendritic protein synthesis machinery. Current research projects are directed toward defining the molecular mechanisms regulating local protein synthesis in neurons, and understanding how these translational mechanisms contribute to normal cognition and the modification of synaptic connectivity in the mammalian brain. Examination of the role of defective translational control in the pathogenesis of specific neuropsychiatric disorders, particularly mental retardation and autism, is a closely related effort. In a complementary line of research, the laboratory is also investigating the molecular and cellular mechanisms responsible for neurodegenerative dementia, with a focus on the role of altered presenilin function in Alzheime?s disease and frontotemporal dementia. Due to the complexity of these problems, which span the gap from molecules to cognitive function, the laboratory employs a multidisciplinary approach, including conditional and inducible genetic manipulations in mice, biochemical, molecular and cell biological analysis, slice electrophysiology and mouse behavior.


View my most recent publications at PubMed

1. T cells and stromal fibroblasts in human tumor microenvironments represent potential therapeutic targets. Barnas JL, Simpson-Abelson MR, Yokota SJ, Kelleher RJ, Bankert RB. Cancer Microenviron. 2010 Mar 31;3(1):29-47. PMID: 21209773
2. Genetics. Gamma-secretase and human disease. Kelleher RJ 3rd, Shen J. Science. 2010 Nov 19;330(6007):1055-6. No abstract available. PMID: 21097925
3.Reciprocal functional modulation of the activation of T lymphocytes and fibroblasts derived from human solid tumors. Barnas JL, Simpson-Abelson MR, Brooks SP, Kelleher RJ Jr, Bankert RB. J Immunol. 2010 Sep 1;185(5):2681-92. Epub 2010 Aug 4. PMID: 20686130

Edit Profile

News & Events


Neurology Associates
15 Parkman Street
Boston MA, 02114-3117
Phone: 617-726-1728

Edit Profile

Back to Top